Related Experiment Video
Updated: Oct 8, 2025

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
Published on: February 16, 2022
Self-limited Polymyalgia Rheumatica-like Syndrome Following mRNA-1273 SARS-CoV-2 Vaccination
Shinji Izuka1, Toshihiko Komai1, Bunki Natsumoto1
1Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Japan.
Abstract:
Polymyalgia rheumatica (PMR) is an inflammatory rheumatic disease characterized by stiffness and aching mainly in the shoulders, neck and hip girdles. The underlying pathogenesis of PMR involves myeloid lineage activation with a high expression of pattern recognition receptors. In addition, vaccination against severe acute respiratory syndrome coronavirus 2 with mRNA-1273 functions as both an immunogen and intrinsic adjuvant. It leads to the activation of innate immunity, resulting in antibody production. We herein report the first case of PMR-like syndrome seven days after mRNA-1273 vaccination. Reassuringly, the symptoms, such as pain of the neck, shoulder girdle and pelvic girdle, as well as elevated inflammatory markers were resolved within a month without glucocorticoid or immunosuppressant administration.
Insights
Polymyalgia rheumatica-like syndrome occurred after mRNA-1273 vaccination. Symptoms resolved within a month without medication, suggesting a transient post-vaccination inflammatory response.
Area of Science:
- Rheumatology
- Immunology
- Vaccinology
Background:
- Polymyalgia rheumatica (PMR) is an inflammatory rheumatic disease affecting shoulders, neck, and hips.
- PMR pathogenesis involves myeloid lineage activation and pattern recognition receptor expression.
- mRNA-1273 vaccination activates innate immunity, acting as an immunogen and adjuvant.
Purpose of the Study:
- To report the first case of a polymyalgia rheumatica-like syndrome following mRNA-1273 vaccination.
- To describe the clinical presentation and resolution of this syndrome.
Main Methods:
- Case report of a patient experiencing PMR-like symptoms after mRNA-1273 vaccination.
- Monitoring of clinical symptoms and inflammatory markers.
Main Results:
- A PMR-like syndrome developed seven days post-mRNA-1273 vaccination.
- Symptoms included neck, shoulder, and pelvic girdle pain with elevated inflammatory markers.
- Resolution of symptoms and inflammatory markers occurred within one month without immunosuppressants.
Conclusions:
- mRNA-1273 vaccination can transiently trigger a PMR-like syndrome.
- This syndrome appears to resolve spontaneously without specific treatment.
- Further investigation into vaccine-induced inflammatory syndromes is warranted.
More Related Videos
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management
Single Nucleotide Polymorphisms-SNPs
Myocarditis I: Introduction
Rheumatic Heart Disease I: Introduction
Pericarditis I: Introduction

